Microcystin-LR stabilizes c-myc protein by inhibiting protein phosphatase 2A in HEK293 cells

Huihui Fan1, Yan Cai2, Ping Xie3

  • 1College of Fisheries, Huazhong Agricultural University, Wuhan, China; Donghu Experimental Station of Lake Ecosystems, State Key Laboratory of Freshwater Ecology and Biotechnology of China, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China.

Toxicology
|March 11, 2014
PubMed

Insights

Microcystin-LR, a potent cyanotoxin, increases c-myc protein and transcription. This occurs by inhibiting protein phosphatase 2A, potentially driving liver cancer development.

Area of Science:

  • Environmental Toxicology
  • Molecular Carcinogenesis

Background:

  • Microcystin-LR (MC-LR) is a prevalent cyanotoxin linked to potential carcinogenicity.
  • The molecular mechanisms of MC-LR-induced cancer, particularly its effect on the proto-oncogene c-myc, are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which Microcystin-LR affects c-myc expression and protein levels.
  • To investigate the role of protein phosphatase 2A (PP2A) in MC-LR's impact on c-myc.

Main Methods:

  • Exposure of HEK293 cells to Microcystin-LR.
  • Coexpression of PP2A and c-myc mutants (c-myc(T58A), c-myc(S62A)).
  • Luciferase reporter assay to assess c-myc promoter activity.

Main Results:

  • Microcystin-LR exposure led to increased c-myc protein levels in cells.
  • MC-LR inhibited PP2A activity, affecting c-myc phosphorylation at serine 62.
  • MC-LR enhanced c-myc promoter activity, suggesting transcriptional activation.

Conclusions:

  • Microcystin-LR stimulates both c-myc transcription and protein stabilization.
  • Inhibition of PP2A activity by MC-LR is a key mechanism for c-myc protein accumulation.
  • These findings suggest a pathway contributing to Microcystin-LR-induced hepatic tumorigenesis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.1K